SFI
CRL icon

Siemens Fonds Invest’s Charles River Laboratories CRL Stock Holding History

Siemens Fonds Invest’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-534
Closed -$201K – 417
2021
Q4 		$201K Sell
534
-2
-0.4% -$777 0.01% 427
2021
Q3 		$221K Buy
+536
New +$223K 0.01% 395

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Siemens Fonds Invest's CRL Position: Q1 2022 in Review

Siemens Fonds Invest sold out of Charles River Laboratories (CRL) in Q1 2022, closing a stake of 534 shares — an estimated $201K sold.

Siemens Fonds Invest first reported a position in CRL in Q3 2021 and held it in 2 quarters. The position peaked at $221K in Q3 2021. 644 funds tracked by Wall St. Rank hold CRL as of Q1 2022.

  • Siemens Fonds Invest reported no remaining Charles River Laboratories position as of Q1 2022 after selling out during the quarter.
  • Siemens Fonds Invest sold 534 Charles River Laboratories shares in Q1 2022, an estimated $201K.
  • Siemens Fonds Invest first reported a position in Charles River Laboratories in Q3 2021 and held it in 2 quarters.
  • Siemens Fonds Invest's Charles River Laboratories position peaked at $221K in Q3 2021.
  • 644 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2022.

Based on Siemens Fonds Invest's 13F filing for Q1 2022, filed 16 May 2022.